World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000394549
Date of registration: 28/04/2015
Prospective Registration: No
Primary sponsor: The George Institute for Global Health
Public title: Renal Replacement Therapy Intensity in Severe Acute Kidney Injury: An Individual Patient Data Meta-analysis of Randomized Trials
Scientific title: Renal Replacement Therapy Intensity in Severe Acute Kidney Injury and its Effect on All-cause Mortality and Recovery to Dialysis Independence: An Individual Patient Data Meta-analysis of Randomized Trials
Date of first enrolment: 09/04/2015
Target sample size: 3600
Recruitment status: Recruiting
URL:  https://anzctr.org.au/ACTRN12615000394549.aspx
Study type:  Observational
Study design:  Purpose: Screening;Duration: Cross-sectional;Selection: Defined population;Timing: Retrospective;  
Phase:  Not Applicable
Countries of recruitment
Australia Germany Italy Netherlands Switzerland United States of America
Contacts
Name: Prof Rinaldo Bellomo   
Address:  10-12 Ievers Terrace, Carlton VIC 3053, Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia Australia
Telephone: 61-3-9496 5992
Email: rinaldo.bellomo@austin.org.au
Affiliation: 
Name: Prof Rinaldo Bellomo   
Address:  10-12 Ievers Terrace, Carlton VIC 3053, Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia Australia
Telephone: 61-3-9496 5992
Email: rinaldo.bellomo@austin.org.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: All randomized controlled trials assessing the effects of different doses of renal replacement therapy (RRT) in patients with AKI.
Exclusion criteria: Patients with chronic kidney disease

Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Renal and Urogenital - Kidney disease
Severe acute kidney injury requiring renal replacement therapy;
Severe acute kidney injury requiring renal replacement therapy
Intervention(s)
Higher intensity haemodialysis, a prescribed dose of 35 to 48 ml/kg/h or defined as published in the original publications
Primary Outcome(s)
All-cause mortality [At trial specific follow-up time points. ]
Secondary Outcome(s)
Renal replacement therapy (RRT) dependence, defined as the proportion of patients who were still RRT dependent at 7, 14, 28, 60 and 90 days, time to recovery to RRT independence [At trial specific follow-up time points]
Secondary ID(s)
Nil known
Source(s) of Monetary Support
Australian National Health and Medical Research Council (NHMRC) project grant
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
NSW Population and Health Services Research Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history